Ambien cr and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is reported as a side effect among people who take Ambien cr (zolpidem tartrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Xanax, and have High blood pressure.

The phase IV clinical study analyzes which people have Fainting when taking Ambien cr. It is created by eHealthMe based on reports of 4,630 people who have side effects when taking Ambien cr from the FDA, and is updated regularly.

What is Ambien cr?

Ambien cr has active ingredients of zolpidem tartrate. It is often used in insomnia. eHealthMe is studying from 5,660 Ambien cr users. Check the latest studies of Ambien cr.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 2,445 drugs and 3,548 conditions by eHealthMe. Check the latest studies of Fainting.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

4,630 people reported to have side effects when taking Ambien cr.
Among them, 62 people (1.34%) have Fainting.

Among these 62 people:

How long have people been on Ambien cr when they have Fainting? *

What is the gender of people who have Fainting when taking Ambien cr? *

female: 53.45 %
male: 46.55 %

What is the age of people who have Fainting when taking Ambien cr? *

What are other drugs people take besides Ambien cr? *

What are other side effects people have besides Fainting? *

Fatigue (feeling of tiredness): 20 people, 32.26%
Dizziness: 16 people, 25.81%
Head Injury: 15 people, 24.19%
Drowsiness: 14 people, 22.58%
Fall: 13 people, 20.97%
Memory Loss: 13 people, 20.97%
Impaired Driving Ability: 11 people, 17.74%
Road Traffic Accident: 11 people, 17.74%
Loss Of Consciousness: 11 people, 17.74%
Drug Ineffective: 11 people, 17.74%

What are the existing conditions these people have? *

High Blood Pressure: 15 people, 24.19%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 11 people, 17.74%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 14.52%
Stress And Anxiety: 7 people, 11.29%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 9.68%
Depression: 6 people, 9.68%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 9.68%
Intervertebral Disc Degeneration (spinal disc degeneration): 4 people, 6.45%
Dry Eyes (lack of adequate tears): 4 people, 6.45%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Ambien cr and have Fainting?

- Check whether Fainting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ambien cr:

Ambien cr (5,660 reports)

Fainting treatments and more:

Fainting (131,321 reports)

Browse all side effects of Ambien cr:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fainting:

Fainting (2,445 drugs)

Browse all the conditions that are associated with Fainting:

Fainting (3,548 conditions)

Related publications that referenced our studies

Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .
Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW, "Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population‐Based Case‐Control Study in Taiwan", The Journal of Clinical Pharmacology, 2017 Mar .
Lin SC, Su YC, Huang YS, Lee CC, "Zolpidem increased cancer risk in patients with sleep disorder: A 3-year follow-up study", Journal of Medical Sciences, 2016 Mar .
Sun Y, Lin CC, Lu CJ, Hsu CY, Kao CH, "Association between zolpidem and suicide: a nationwide population-based case-control study", InMayo Clinic Proceedings, 2016 Mar .
Liao KF, Lin CL, Lai SW, Chen WC, "Zolpidem use associated with increased risk of pyogenic liver abscess: a case-control study in Taiwan", Medicine, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on zolpidem tartrate (the active ingredients of Ambien cr) and Ambien cr (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.